Mirae Asset Global Etfs Holdings Ltd. Tyra Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 11,109 shares of TYRA stock, worth $179,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,109
Previous 6,508
70.7%
Holding current value
$179,743
Previous $104,000
150.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$169 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$104 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$75.4 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$71.4 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$65.6 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $679M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...